Literature DB >> 31520767

Communicating the External Beam Radiation Experience (CEBRE): Perceived Benefits of a Graphic Narrative Patient Education Tool.

Ritu Arya1, Tomoko Ichikawa2, Brian Callender3, Olivia Schultz4, Marina DePablo5, Kira Novak2, Shanyanyan Li2, Apoorva Shenoy2, Andrea Everman2, Sarah Braunstein2, Isabel Dec2, Sonia Lala2, Yachu Feng2, Laura Biltz2, Anne R McCall1, Daniel W Golden6.   

Abstract

PURPOSE: Current radiation oncology patient education materials exceed national readability recommendations. A graphic narrative educational tool, the Communicating the External Beam Radiation Experience (CEBRE) discussion guide, was developed to facilitate patient-provider communication. A pilot study evaluated perceived benefits of CEBRE for patients and physicians. METHODS AND MATERIALS: CEBRE was designed through a collaboration between physicians and designers. Designers interviewed patients, family members, and the clinical team. Interviews were coded for themes, leading to the design principles that drove the design of CEBRE, including a graphic narrative component. CEBRE explains the radiation therapy care path. Readability was measured using the Flesch-Kincaid test. Patients receiving radiation therapy or in follow-up and practicing radiation oncologists reviewed CEBRE and completed independent surveys. Each survey included modified versions of the Systems Usability Score (SUS) and Spielberger State-Trait Anxiety Inventory (STAI) short form, along with questions unique to CEBRE. Likert-type scores are reported as median (interquartile range).
RESULTS: CEBRE scores at a 5.4 Flesch-Kincaid grade level. Thirty-four patients and 15 radiation oncologists completed surveys. Patients had completed a high school/general equivalency degree (18%), a 2-year degree or some college (50%), or at least 4 years of college (32%). Patient and physician responses were concordant. On a scale of 1 to 5 for modified SUS and 1 to 4 for modified STAI ("strongly disagree" to "strongly agree") the SUS scores were 4 (4-5) and 4 (4-5) and STAI scores were 3 (3-4) and 3 (3-3.5) for patients and providers, respectively. This indicates CEBRE is usable and would decrease anxiety. Compared with text, the graphic narrative component of CEBRE was rated as "quite helpful" (4 [4-5]).
CONCLUSIONS: CEBRE, a graphic narrative education tool developed through a novel collaboration between designers and radiation therapy stakeholders, is accessible for patients and practical to facilitate patient-provider discussion. Perceived benefits demonstrating high usability and the potential to decrease patient anxiety warrant further prospective investigation of CEBRE in the clinical setting.
Copyright © 2019 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31520767      PMCID: PMC7064379          DOI: 10.1016/j.prro.2019.09.001

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  33 in total

1.  Sharing decisions in cancer care.

Authors:  M Gattellari; P N Butow; M H Tattersall
Journal:  Soc Sci Med       Date:  2001-06       Impact factor: 4.634

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 3.  Breast cancer disparities and decision-making among U.S. women.

Authors:  Georgia N L Johnston Polacek; Mary Carol Ramos; Robert L Ferrer
Journal:  Patient Educ Couns       Date:  2006-07-25

4.  Readability of patient education materials from professional societies in radiation oncology: are we meeting the national standard?

Authors:  John Byun; Daniel W Golden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

5.  Exploring graphic pathographies in the medical humanities.

Authors:  Maria Vaccarella
Journal:  Med Humanit       Date:  2012-11-28

Review 6.  Depression and anxiety in patients with cancer.

Authors:  Alexandra Pitman; Sahil Suleman; Nicholas Hyde; Andrew Hodgkiss
Journal:  BMJ       Date:  2018-04-25

7.  Effects of preparatory patient education for radiation oncology patients.

Authors:  L C Rainey
Journal:  Cancer       Date:  1985-09-01       Impact factor: 6.860

8.  The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI).

Authors:  T M Marteau; H Bekker
Journal:  Br J Clin Psychol       Date:  1992-09

9.  International Patient Decision Aid Standards (IPDAS): beyond decision aids to usual design of patient education materials.

Authors:  Margaret Holmes-Rovner
Journal:  Health Expect       Date:  2007-06       Impact factor: 3.377

10.  What information is communicated by radiation therapists to patients during education sessions on the first day of treatment?

Authors:  Lena Schnitzler; Sian K Smith; Heather L Shepherd; Joanne M Shaw; Skye Dong; Robin M Turner; Kristine Sørensen; Haryana M Dhillon
Journal:  Eur J Cancer Care (Engl)       Date:  2018-09-11       Impact factor: 2.520

View more
  3 in total

1.  Navigating Radiation Therapy During COVID-19 Using YouTube as a Source of Information.

Authors:  Zhang Hao Jim Li; Inhwa Kim; Meredith Giuliani; Paris-Ann Ingledew
Journal:  J Cancer Educ       Date:  2022-01-14       Impact factor: 2.037

2.  Usability: An introduction to and literature review of usability testing for educational resources in radiation oncology.

Authors:  Heather L Keenan; Simon L Duke; Heather J Wharrad; Gillian A Doody; Rakesh S Patel
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2022-09-17

3.  Readability of Patient Education Materials From High-Impact Medical Journals: A 20-Year Analysis.

Authors:  Michael K Rooney; Gaia Santiago; Subha Perni; David P Horowitz; Anne R McCall; Andrew J Einstein; Reshma Jagsi; Daniel W Golden
Journal:  J Patient Exp       Date:  2021-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.